¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Maximum Strength Tylenol Sinus Night Time Caplets"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maximum absorption
    ÃÖ´ëÈí¼ö
  • maximum acceptable daily intake
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®
  • maximum allowable concentration
    ÃÖ´ëÇã¿ë³óµµ
  • maximum allowable dose
    ÃÖ´ëÇã¿ë·®
  • maximum allowable limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum allowable value
    ÃÖ´ëÇã¿ëÄ¡
  • maximum breathing capacity
    ÃÖ´ëÈ£Èí¿ë·®
  • maximum cardiac output
    ÃÖ´ë½ÉÀå¹ÚÃâ·®
  • maximum compliance
    ÃÖ´ë¼øÀÀµµ
  • maximum dose
    1. ÃÖ´ë¿ë·® 2. ÃÖ´ë¼±·®
  • maximum expiratory flow rate
    ÃÖ°í³¯¼ûÀ¯¼Ó, ÃÖ°íÈ£±âÀ¯¼Ó
  • maximum flow rate
    1. ÃÖ°íÀ¯¼Ó 2. ÃÖ°íÈ帧¼Óµµ 3. ÃÖ´ëÀ¯·®
  • maximum heart rate
    ÃÖ´ë½ÉÀå¹Úµ¿¼ö, ÃÖ´ë½É¹Ú¼ö
  • maximum intensity projection
    ÃÖ´ë°­µµÅõ»ç
  • maximum midexpiratory flow
    ÃÖ´ëÁß°£³¯¼ûÀ¯·®, ÃÖ´ëÁß°£È£±âÀ¯·®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • exposure time
    ³ëÃâ½Ã°£, Æø·Î½Ã°£
  • gastric emptying time
    À§¹èÃâ½Ã°£
  • inspiratory pause time
    µé¼ûÈĽ¬´Â½Ã°£, Èí±âÈÄÈÞÁö½Ã°£
  • inspiratory phase time
    µé¼û½Ã°£, Èí±â½Ã°£
  • latent time
    Àẹ½Ã°£
  • mean survival time
    Æò±Õ»ýÁ¸½Ã°£
  • partial thromboplastin time
    ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • reaction time
    ¹ÝÀÀ½Ã°£
  • recovery time
    ȸº¹½Ã°£
  • repetition time
    ¹Ýº¹½Ã°£
  • scrub time
    ¼Õ¾Ä´Â½Ã°£
  • survival time
    »ýÁ¸±â°£
  • thrombin time
    Æ®·Òºó½Ã°£
  • transit time
    ÀüÀ̽ð£, Åë°ú½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • physical strength
    ü·Â
  • strength
    Èû, ¼¼±â
  • shearing strength
    ¾ù°¥¸²¼¼±â, Àü´Ü°­µµ
  • tearing strength
    °Áü¼¼±â, Àο­µµ
  • tensile strength
    ´ç±èÈû, ½ÅÀå°­µµ
  • tinting strength
    Âø»öÈû, Âø»ö·Â
  • ultimate strength
    ±ØÇѼ¼±â, ±ØÇѰ­µµ
  • wet strength
    ½ÀÀ±µµ
  • wound strength
    â»óÈû
  • yield strength
    Ç׺¹¼¼±â
  • maximum absorption
    ÃÖ´ëÈí¼ö
  • maximum compliance
    ÃÖ´ë¼øÀÀµµ
  • maximum allowable concentration
    ÃÖ´ëÇã¿ë³óµµ
  • maximum permissible concentration
    ÃÖ´ëÇã¿ë³óµµ
  • maximum urea clearance
    ÃÖ°í¿ä¼Òû¼Ò, ÃÖ°í¿ä¼Òû¼ÒÀ²
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • groove for superior petrosal sinus
    À§¹ÙÀ§Á¤¸Æµ¿±¼°í¶û
  • groove for superior petrosal sinus
    À§¾Ï¼®Á¤¸Æµ¿°í¶û, »óÃßüÁ¤¸Æµ¿±¸.
  • groove for superior sagittal sinus
    À§½Ã»óÁ¤¸Æµ¿°í¶û, »ó½Ã»óÁ¤¸Æµ¿__
  • groove for superior sagittal sinus
    À§½Ã»óÁ¤¸Æµ¿±¼°í¶û
  • groove for transverse sinus
    °¡·ÎÁ¤¸Æµ¿°í¶û, Ⱦµ¿__üô÷Óϵ).
  • groove for transverse sinus
    °¡·ÎÁ¤¸Æµ¿±¼°í¶û
  • groove for transverse sinus
    °¡·ÎÁ¤¸Æµ¿°í¶û, Ⱦµ¿±¸(üô÷Óϵ).
  • hiatus sinus maxillaris <³ª>
    »ó¾Çµ¿ÀÔ__ »ó¾Çµ¿¿­°ø.
  • hiatus sinus maxillaris <³ª>
    »ó¾Çµ¿¿­°ø, »ó¾Çµ¿ÀÔ±¸{ÇØ}
  • histiocytosis,sinus
    (Á¤¸Æ)µ¿
  • hypersensitive carotid sinus
    °ú¹Î¼º °æµ¿¸Æµ¿(¡­ ÔÑØæ÷Ó).
  • inferior petrosal sinus
    ¾Æ·¡¾Ï¼®Á¤¸Æµ¿, ÇÏÃßüÁ¤¸Æµ¿(ù»õÞô÷ð¡ØæÔÑ).
  • inferior petrosal sinus
    ¾Æ·¡¹ÙÀ§Á¤¸Æµ¿±¼
  • inferior sagittal sinus
    ¾Æ·¡½Ã»óÁ¤¸Æµ¿, ÇϽûóÁ¤¸Æµ¿(ù»ãÅßÒð¡ØæÔÑ).
  • inferior sagittal sinus
    ¾Æ·¡½Ã»óÁ¤¸Æµ¿±¼
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pavor nocturnus, see night terror or sleep terror disorder
    ¾ß°æÁõ
  • saturday night palsy
    Åä¿äÀϾ߰£¸¶ºñ(÷Ïèøìíå¨ÊàØ«Ýö)
  • saturday night paralysis
    Åä¿äÀϹ㠸¶ºñ.
  • saturday night paralysis
    Åä¿äÀϹ㸶ºñ.
  • saturday night paralysis
    Åä¿äÀϹ㸶ºñ(÷Ïèøìí¡­Ø«Ýö)
  • cervical sinus branchial sinus
    ¸ñµ¿±¼
  • back strength
    ¹è±Ù·Â.
  • bending strength
    ±¼°î °­µµ(ÏÝÍØË­Óø).
  • bonding strength
    °áÇÕ·Â(Ì¿ùêæ³).
  • edge-strength
    ¿¬´Ü°­µµ(æÞӮ˭öô).
  • ego strength
    ÀÚ¾ÆÀÇ Èû
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • flexure strength
    ¿ä°î°­µµ(èúÍØË­öô).
  • fracture strength
    ÆÄÀý°­µµ.
  • fracture strength
    ÆÄÀý °­µµ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Coronary sinus (partial)
    ½ÉÀåÁ¤¸Æµ¿±¼(ºÎºÐ)
    [¿¾ ¿ë¾î] °ü»óÁ¤¸Æµ¿
  • Orifice of coronary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼±¸¸Û
    [¿¾ ¿ë¾î] ½ÉÀåÁ¤¸Æµ¿±¸
  • Valve of conary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] °ü»óÁ¤¸Æµ¿ÆÇ
  • Valve of coronary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] °ü»óÁ¤¸ÆÆÇ
  • Inferior petrosal sinus
    ¾Æ·¡¹ÙÀ§Á¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] ÇÏÃßüÁ¤¸Æµ¿
  • Groove for inferior petrosal sinus
    ¾Æ·¡¹ÙÀ§Á¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] ÇÏÃßüµ¿±¸
  • Inferior sagittal sinus
    ¾Æ·¡½Ã»óÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] ÇϽûóÁ¤¸Æµ¿
  • Definitive urogenital sinus
    ¿Ï¼ººñ´¢»ý½Äµ¿±¼
    [¿¾ ¿ë¾î] ¿Ï¼º¿ä»ý½Äµ¿
  • Primitive urogenital sinus
    ¿ø½Ãºñ´¢»ý½Äµ¿±¼
    [¿¾ ¿ë¾î] ¿ø½Ã¿ä»ý½Äµ¿
  • Superior petrosal sinus
    À§¹ÙÀ§Á¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] »óÃßüÁ¤¸Æµ¿
  • Groove for superior petrosal sinus
    À§¹ÙÀ§Á¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] »óÃßüµ¿±¸
  • Superior sagittal sinus
    À§½Ã»óÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] »ó½Ã»óÁ¤¸Æµ¿
  • Groove for superior sagittal sinus
    À§½Ã»óÁ¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] »ó½Ã»óµ¿±¸
  • Maxillary sinus branches
    À§Åε¿±¼°¡Áö
    [¿¾ ¿ë¾î] »ó¾Çµ¿Áö
  • Maxillary sinus
    À§ÅλÀµ¿±¼
    [¿¾ ¿ë¾î] »ó¾Çµ¿
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • thermal death time
    ¿­»ç½Ã°£ (æðÞÝãÁÊà)
  • time constant
    ½Ã°£»ó¼ö (ãÁÊàßÈâ¦)
  • time constant of a reaction
    ¹ÝÀÀ ½Ã°£»ó¼ö (ÚãëëãÁÊàßÈâ¦)
  • time factor effect
    ½Ã°£ÀÎÀÚ È¿°ú (ãÁÊàì×í­üùÍý)
  • transient time
    °úµµ±â ½Ã°£(ΦԤѢãÁÊà)
  • turnover time
    Àüȯ½Ã°£(ï®üµãÁÊà)
  • zero time binding DNA
    ¿µ½Ã(çÍãÁ) °áÇÕ(Ì¿ùê) DNA
  • zero time control
    ¿µ½Ã(çÍãÁ) ´ëÁ¶(ÓßðÎ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • umbilical sinus
    ¹è²Åµ¿, Á¦µ¿
  • urachal sinus
    ´¢¸·°üµ¿
  • urogenital sinus
    ºñ´¢»ý½Äµ¿, ¿ä»ý½Äµ¿
  • venous sinus
    Á¤¸Æµ¿
  • acquisition time
    ȹµæ½Ã°£
  • arm to lung time test
    ÆÈÆó¼øÈ¯½Ã°£½ÃÇè
  • correlation time
    »ó°ü½Ã°£
  • data acquisition time
    ÀÚ·áȹµæ½Ã°£
  • delay time
    Áö¿¬½Ã°£
  • diffusion time
    È®»ê½Ã°£
  • doubling time
    ¹è°¡½Ã°£
  • echo time [=TE]
    ¿¡Äڽð£
  • elapsed time
    °æ°ú½Ã°£
  • exposure time
    ³ëÃâ½Ã°£, Á¶ ½Ã°£
  • fast time constant circuit
    °í¼Ó½Ã°£°íÁ¤È¸·Î
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TT tablet triturate; tactile tension; tendon transfer; test tube; testicular torsion; tetanus toxin; te...
Tmax maximum threshold; time of maximum concentration
SRT sedimentation rate test; simple reaction time; sinus node recovery time; sitting root test; speech r...
ASD Atrial Septal Defect
  Types of ASD
  1. Ostium Primum ASD
  ...
CSI calculus surface index; cancer serum index; cavernous sinus infiltration; cervical spine injury; che...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LISS Low ionic strength solutions
RMS Respiratory muscle strength
SBS Shear bond strength
ST Strength training
TBS Tensile Bond Strength
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • maximum
    ÃÖ´ë, ÃÖ°í, ±ØÄ¡
    1. °¡Àå °¡´É¼ºÀÌ Àִ ȤÀº ½ÇÁ¦ÀÇ °á°ú ȤÀº ¼ö·®. 2. º´À̳ª °úÁ¤ÀÇ °íºñ, ÀýÁ¤.
  • maximum accumulation dose
    ÃÖ´ë ÃàÀû·®
  • maximum allowable concentration
    ÃÖ´ë Çã¿ë ³óµµ
  • maximum allowable limit
    ÃÖ´ë Çã¿ë ÇѰè
  • maximum and minimum thermometer
    ÃÖ°í ÃÖÀú ¿Âµµ°è
  • maximum comfortable opening
    ÃÖ´ë ¹«Å뼺 °³±¸
  • maximum discrimination score
    ÃÖ´ë ¸í·áÄ¡
  • maximum expiratory flow rate
    ÃÖ´ë È£±â À¯·®·ü
  • maximum foundation plane
    ÀÇÄ¡»ó Æò±Õ Àú¸é
  • maximum intercuspal contact
    ÃÖ´ë ±³ÇÕ Á¢ÃË
  • maximum intercuspation
    ÃÖ´ë ±³µÎ°£À§, ÃÖ´ë ±³µÎ °¨ÇÕ, ÃÖ´ë ±³ÇÕ
    »ó, ÇÏ¾Ç Ä¡¾ÆÀÇ ±³µÎµéÀÌ °¡Àå ¸¹ÀÌ Á¢ÃËÇÏ´Â °Í.
  • maximum mid-expiratory flow rate
    ÃÖ´ë Áß°£ È£±â À¯Ãâ ¼Óµµ
  • maximum oxygen consumption
    ÃÖ´ë »ê¼Ò ¼Ò¸ð·®
  • maximum permissible concentration
    ÃÖ´ë Çã¿ë ³óµµ
  • maximum permissible exposure
    ÃÖ´ë Çã¿ë ³ëÃâ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
ultimate strength The maximum stress achieved prior to failure of a component on a single application of the load.
(05 Mar 2000)
fatigue strength The stress level below which a particular component will survive an indefinite number of load cycles (typically about 50% of the ultimate strength of the component).
(05 Mar 2000)
activated clotting time The most common test used for coagulation time in cardiovascular surgery.
(05 Mar 2000)
activated partial thromboplastin time The time needed for plasma to form a fibrin clot following the addition of calcium and a phospholipid reagent; used to evaluate the intrinsic clotting system.
(05 Mar 2000)
A-H conduction time Forward conduction of the cardiac impulse from atria to ventricles via the A-V node or any bypass tract, represented in the electrocardiogram by the P-R interval. P-H conduction time is from the onset of the P wave to the first high frequency component of the His bundle electrogram (normally 119 &plusmn; 38 msec); A-H conduction time is from the onset of the first high frequency component of the atrial electrogram to the first high frequency component of the His bundle electrogram (normally 92 &plusmn; 38 msec); P-A conduction time is from the onset of the P wave to the onset of the atrial electrogram (normally 27 &plusmn; 18 msec).
(05 Mar 2000)
association time Time elasping between a stimulus and the verbalised response to it.
(05 Mar 2000)
biologic time The concept that our appreciation of time varies with age and is governed by the neural organization of the individual; it obeys a logarithmic rather than an arithmetic law.
(05 Mar 2000)
bleeding time <haematology> A test which measures the time it takes for small blood vessels to close off and bleeding to stop. Abnormal results can be seen in those with congenital or acquired platelet function disorders or thrombocytopenia.
(27 Sep 1997)
blood circulation time Determination of the shortest time interval between the injection of a substance in the vein and its arrival at some distant site in sufficient concentration to produce a recognizable end result. It represents approximately the inverse of the average velocity of blood flow between two points.
(12 Dec 1998)
P-A conduction time See: atrioventricular conduction.
(05 Mar 2000)
generation time <cell biology> Time taken for a cell population to double in numbers and thus equivalent to the average length of the cell cycle.
(18 Nov 1997)
reaction time The time from the onset of a stimulus until the organism responds.
(12 Dec 1998)
real-time ultrasonography Rapid serial ultrasound images produced using a phased array or scanning transducer; produces a video display of organ motion, such as heart valve or foetal motion.
(05 Mar 2000)
recognition time The interval between the application of a stimulus and the recognition of its nature.
(05 Mar 2000)
partial thromboplastin time Test of the intrinsic (factors viii, ix, xi, and xii) and common (fibrinogen, prothrombin, factors v and x) pathways of coagulation in which a mixture of plasma and phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides) is recalcified and the time required for the appearance of fibrin strands measured. Activation may be provided by contact with the glass tube or exposure to activators (e.g., ellagic acid, particulate silicates such as diatomaceous earth or kaolin) before addition of the calcium chloride. It is used as a screening test and to monitor heparin therapy.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • night crawler
    ¹ã¿¡ ±â¾î³ª¿À´Â Å« Áö··ÀÌ;¹ã¿¡ µ¹¾Æ´Ù´Ï´Â »ç¶÷
  • night crow
    ¹ã¿¡ ¿ì´Â »õ;(ƯÈ÷)ÇØ¿À¶ó±â
  • night editor
    (½Å¹®)Á¶°£ÀÇ ÆíÁý Ã¥ÀÓÀÚ
  • night fighter
    ¾ß°£ ¿ä°Ý ÀüÅõ±â
  • night flower
    ¹ã¿¡ ÇÇ´Â ²É(´Þ¸ÂÀÌ ²Éµî)
  • night glass
    ¾ß°£¿ë ¸Á¿ø°æ;¾ß°£¿ë ½Ö¾È°æ
  • night heron
    ÇØ¿À¶ó±â
  • night latch
    ¾ß°£ ÀÚ¹°¼è(latchkey)(¾È¿¡¼­´Â ¼ÕÀâÀÌ·Î ¹Ù±ù¿¡¼­´Â ¿­¼è·Î Á¶ÀÛ)
  • night letter
    ¾ß°£¹ß¼ÛÀüº¸(ÀÌÆ±³¯ ¾ÆÄ§¿¡ ¹è´ÞµÇ¸ç ¿ä±ÝÀÌ ½Ó,100´Ü¾î À̳»)
  • night life
    ¹ãÀÇ À¯Èï;¹ã³îÀÌ
  • night lifer
    ¹ãÀ¯ÈïÀ» ÇÏ´Â »ç¶÷
  • night line
    ¹ã³¬½ÃÁÙ(¹Ì³¢¸¦ ´Þ¾Æ ¹ã¿¡ ¹°¼Ó¿¡ ³Ö¾îµÒ)
  • night man
    ¾ß°£ Á÷¾÷À» °¡Áø »ç¶÷;(ƯÈ÷)¾ß°æ²Û
  • night nurse
    ¾ß°£ ±Ù¹«°£È£»ç
  • night owl
    ¹ã´Êµµ·Ï ÀÚÁö ¾Ê´Â ¹ö¸©ÀÌ ÀÖ´Â »ç¶÷;¹ãÀÏÇÏ´Â »ç¶÷;½ïµ¶»õ·ù(nightawk)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á